We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
-6.37%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$3.55B
AUM Growth
-$772M
Cap. Flow
-$469M
Cap. Flow %
-13.21%
Top 10 Hldgs %
58.31%
Holding
161
New
16
Increased
39
Reduced
56
Closed
15

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$126M
2
TCOM icon
Trip.com Group
TCOM
+$77.7M
3
ICVX
Icosavax, Inc. Common Stock
ICVX
+$26.7M
4
BTRS
BTRS Holdings Inc. Class 1 Common Stock
BTRS
+$23.5M
5
IDYA icon
IDEAYA Biosciences
IDYA
+$21.6M

Top Sells

Rank Stock Value
1
ALLY icon
Ally Financial
ALLY
+$177M
2
LPX icon
Louisiana-Pacific
LPX
+$118M
3
WAB icon
Wabtec
WAB
+$106M
4
AEO icon
American Eagle Outfitters
AEO
+$102M
5
YUMC icon
Yum China
YUMC
+$52M

Sector Composition

Rank Sector Weight
1 Technology 23.17%
2 Industrials 21.06%
3 Consumer Discretionary 20.58%
4 Healthcare 13.81%
5 Materials 10.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALBO
51
DELISTED
Albireo Pharma Inc
ALBO
$7.66M 0.22%
245,381
+39,489
+19% +$1.22M
ACIU icon
52
AC Immune
ACIU
$240M
$7.13M 0.2%
1,062,462
+634,926
+149% +$4.55M
SYNH
53
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$7.07M 0.2%
80,841
-26,913
-25% -$2.44M
PACB icon
54
Pacific Biosciences
PACB
$370M
$6.67M 0.19%
261,242
– –
YUMC icon
55
Yum China
YUMC
$16.3B
$6.34M 0.18%
109,179
-845,363
-89% -$52M
RBLX icon
56
Roblox
RBLX
$27B
$6.3M 0.18%
83,344
+50,840
+156% +$4.17M
LYB icon
57
LyondellBasell Industries
LYB
$19.2B
$6.27M 0.18%
66,802
-485,250
-88% -$47.6M
HCM icon
58
HUTCHMED
HCM
$2.17B
$5.79M 0.16%
158,054
– –
ASMB icon
59
Assembly Biosciences
ASMB
$529M
$5.75M 0.16%
137,751
– –
CTMX icon
60
CytomX Therapeutics
CTMX
$754M
$5.49M 0.15%
1,078,103
– –
XGN icon
61
Exagen
XGN
$166M
$5.44M 0.15%
400,000
– –
CYPH
62
Cypherpunk Technologies Inc
CYPH
$73.3M
$5.33M 0.15%
132,795
+41,790
+46% +$786K
PVLA
63
Palvella Therapeutics
PVLA
$2.27B
$5.32M 0.15%
12,854
-1,705
-12% -$594K
MRUS
64
DELISTED
Merus
MRUS
$5.28M 0.15%
240,037
+25,063
+12% +$537K
BIO icon
65
Bio-Rad Laboratories Class A
BIO
$9.42B
$4.84M 0.14%
6,485
-5,074
-44% -$3.8M
IMVT icon
66
Immunovant
IMVT
$8.25B
$4.82M 0.14%
+555,065
New +$5.01M
CLF icon
67
Cleveland-Cliffs
CLF
$6.99B
$4.8M 0.14%
242,246
+50,409
+26% +$1.15M
GRUB
68
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$4.64M 0.13%
319,228
-74,135
-19% -$1.3M
ZYME icon
69
Zymeworks
ZYME
$1.67B
$4.51M 0.13%
155,412
+52,468
+51% +$1.74M
MYOV
70
DELISTED
Myovant Sciences Ltd.
MYOV
$4.38M 0.12%
195,211
– –
IMTX icon
71
Immatics
IMTX
$1.32B
$4.32M 0.12%
332,356
– –
PRTA icon
72
Prothena Corp
PRTA
$450M
$4.31M 0.12%
60,512
-41,393
-41% -$2.57M
FULC icon
73
Fulcrum Therapeutics
FULC
$297M
$4.29M 0.12%
152,186
– –
OCFT
74
DELISTED
OneConnect Financial Technology
OCFT
$4.1M 0.12%
100,085
-65,529
-40% -$4.15M
ZLAB icon
75
Zai Lab
ZLAB
$2.62B
$4.02M 0.11%
38,170
-6,490
-15% -$932K
1 2
3
4 5

Similar funds

LCG
Lisanti Capital Growth New York $397M AUM 178.66% 1-Year Est. Return
EH
EMG Holdings Old Greenwich, Connecticut $397M AUM 9.97% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
GPC
Greenstone Partners & Co Larkspur, California $395M AUM 35.56% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Platinum Investment Management's Q3 2021 Portfolio in Review

As of Q3 2021, Platinum Investment Management held 161 positions worth $3.55B, down 18% from $4.32B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Platinum Investment Management withdrew a net $469M in Q3 2021, closing 15 positions and reducing 56 holdings. Its most notable exit was Wabtec, an estimated $106M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Platinum Investment Management opened a new position in Icosavax, Inc. Common Stock worth $23.3M.

  • Platinum Investment Management's largest Q3 2021 buy was Icosavax, Inc. Common Stock: 786,575 shares worth $23.3M.
  • Platinum Investment Management added most to Alibaba in Q3 2021, an estimated $126M increase.
  • Platinum Investment Management's biggest Q3 2021 reduction was Ally Financial, cutting an estimated $177M.
  • Platinum Investment Management fully exited Wabtec in Q3 2021, selling an estimated $106M.
  • Platinum Investment Management's ten largest holdings make up 58% of its $3.55B portfolio in Q3 2021.
  • Platinum Investment Management opened 16 new positions and closed 15 in Q3 2021.
  • Platinum Investment Management's portfolio value fell 18% quarter-over-quarter to $3.55B.

Based on Platinum Investment Management's 13F filing for Q3 2021, filed 9 Nov 2021.